None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: [1] Males and females aged 20-69 years working at DKS Co., Ltd.. [2] Individuals whose written informed consent has been obtained.
Exclusion criteria
Exclusion criteria: [1] Individuals who are patients of lifestyle disease (ex. high blood pressure and diabetes), rheumatism, hepatic disorder, kidney disorder and other chronic diseases and take medicine. [2] Individuals who have a history of medical treatment of malignancy, heart failure, heart infarction. [3] Individuals who have a history of allergies of a food or medicine including a component of the test food. [4] Females who are pregnant or lactating, or want to become pregnant. [5]Individuals who is participating or participated in other clinical studies in the past 3 months. [6] Individuals who cannot obey instructions by the principal or medical staffs. [7] Individuals judged inappropriate for the study by the principal.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood kinetics (before ingestion, and 30minutes 1,2 hours after ingestion.) | — |
Secondary
| Measure | Time frame |
|---|---|
| *Secondary indexes [1] Body measurements (1) [2] Vital signs (1) [3] Hematologic test (1) [4] Blood biochemical test (1) [5] Urine analysis (1) [6] Doctor's questions (2) (1):Before ingestion. (2):Before ingestion, and 2 hours after ingestion. | — |
Countries
Japan
Contacts
DKS Co. Ltd. Life Sciences Business Headquarters